Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts

Autor: Duffy, Fergal J, Thompson, Ethan, Downing, Katrina, Suliman, Sara, Mayanja-Kizza, Harriet, Boom, W Henry, Thiel, Bonnie, Weiner Iii, January, Kaufmann, Stefan HE, Dover, Drew, Tabb, David L, Dockrell, Hazel M, Ottenhoff, Tom HM, Tromp, Gerard, Scriba, Thomas J, Zak, Daniel E, Walzl, Gerhard, GC6-74 Consortium

Biomarkers that predict who among recently Mycobacterium tuberculosis (MTB)-exposed individuals will progress to active tuberculosis are urgently needed. Intracellular microRNAs (miRNAs) regulate the host response to MTB and circulating miRNAs (c-miR

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::c02a356900de14366739377f485fe5f8

Transcription in Mycoplasma pneumoniae.

Autor: Weiner III, January, Herrmann, Richard, Browning, Glenn F.

Publikováno v: Nucleic Acids Research; Nov2000, Vol. 28 Issue 22, p4488-4496, 9p

A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts.

Autor: Duffy FJ; The Center for Infectious Disease Research, Seattle, WA, United States., Thompson E; The Center for Infectious Disease Research, Seattle, WA, United States., Downing K; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Suliman S; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Mayanja-Kizza H; Department of Medicine, Makerere University, Kampala, Uganda.; Department of Microbiology, Makerere University, Kampala, Uganda., Boom WH; Case Western Reserve University, Cleveland, OH, United States., Thiel B; Case Western Reserve University, Cleveland, OH, United States., Weiner Iii J; Max Planck Institute for Infection Biology, Berlin, Germany., Kaufmann SHE; Max Planck Institute for Infection Biology, Berlin, Germany., Dover D; The Center for Infectious Disease Research, Seattle, WA, United States., Tabb DL; DST/NRF Centre of Excellence for Biomedical TB Research and MRC Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa., Dockrell HM; Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom., Ottenhoff THM; Department of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands., Tromp G; DST/NRF Centre of Excellence for Biomedical TB Research and MRC Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa., Scriba TJ; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Zak DE; The Center for Infectious Disease Research, Seattle, WA, United States., Walzl G; DST/NRF Centre of Excellence for Biomedical TB Research and MRC Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.

Publikováno v: Frontiers in immunology [Front Immunol] 2018 Apr 13; Vol. 9, pp. 661. Date of Electronic Publication: 2018 Apr 13 (Print Publication: 2018).